Mental retardation medical therapy

Revision as of 03:19, 20 July 2021 by Chelsea Mae Nobleza (talk | contribs) (→‎Medical Therapy)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Mental retardation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mental retardation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mental retardation medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mental retardation medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mental retardation medical therapy

CDC on Mental retardation medical therapy

Mental retardation medical therapy in the news

Blogs on Mental retardation medical therapy

Directions to Hospitals Treating Mental retardation

Risk calculators and risk factors for Mental retardation medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Chelsea Mae Nobleza, M.D.[2]

Overview

Some confirmed etiologies for intellectual disabilities can be prevented with different treatment modalities such as enzyme supplementation or chelation in cases of Wilson's disease. Symptomatic treatment is also instituted in cases of seizures in tuberous sclerosis.

Medical Therapy

Medical intervention for identified causes of intellectual disability should be instituted. [1]

References

  1. Kishore MT, Udipi GA, Seshadri SP (January 2019). "Clinical Practice Guidelines for Assessment and Management of intellectual disability". Indian J Psychiatry. 61 (Suppl 2): 194–210. doi:10.4103/psychiatry.IndianJPsychiatry_507_18. PMC 6345136. PMID 30745696.

Template:WH Template:WS